Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to evaluate the safety and efficacy of Luliconazole Cream 1% when applied topically for 7 days in pediatric subjects 2 years to 17 years of age with tinea corporis.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02491112
Study type Interventional
Source Valeant Pharmaceuticals
Contact Anya Loncaric, MS
Phone 510-259-5284
Email aloncaric@solta.com
Status Not yet recruiting
Phase Phase 4
Start date October 2015
Completion date March 2016

See also
  Status Clinical Trial Phase
Completed NCT02902822 - Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo N/A
Completed NCT04265521 - Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet N/A
Completed NCT02582177 - Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis Phase 3
Completed NCT03823040 - Clinical Assessment of Oxiconazole Nitrate Solid Lipid Nanoparticles Loaded Gel Phase 1
Recruiting NCT02759900 - Using a Cold Atmospheric Plasma Device to Treat Skin Disorders N/A
Completed NCT00771342 - Efficacy Study to Evaluate the Effect of Nitric Oxide on the Treatment of Tinea Pedis (Athlete's Foot) Phase 2
Not yet recruiting NCT03471455 - Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis Phase 2